Frailty check could flag risky meds in seniors at ER
NCT ID NCT07282379
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will check if a simple frailty score (ISAR) can predict medication problems in elderly patients visiting the emergency department. Researchers will review the medical records of 300 patients aged 75 and older, looking for inappropriate prescriptions and dangerous drug interactions. The goal is to give pharmacists a quick way to prioritize which patients need a medication review, without changing any care during the study.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could give emergency departments a simple tool to identify which elderly patients need a pharmacist's medication review most urgently.
What could go wrong
This is an observational study, not a treatment trial. It only looks for a link between frailty and medication issues, so it won't directly improve patient care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FRAILTY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hôpital Riviera-Chablais (Vaud-Valais), service des urgences
Rennaz, Canton of Vaud, 1847, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••